Active middle ear implant for sensorineural hearing loss

Medical Services Advisory Committee
Record ID 32015000920
English
Authors' objectives: An active middle ear implant is used in individuals with mild to severe sensorineural hearing loss who cannot use or sufficiently benefit from conventional hearing aids. However, these individuals can still benefit from the amplification of sound. Individuals with sensorineural hearing loss will have air conduction hearing thresholds within the mild to severe range. All active middle ear implant candidates will have speech perception discrimination of at least 50% correct with appropriate amplified sound.
Authors' recommendations: After considering the available evidence presented in relation to safety, clinical effectiveness and cost-effectiveness of partially implantable active middle ear implant (AMEI) for sensorineural hearing loss (SNHL), MSAC did not support public funding for the use of this device in patients with SNHL due to substantially uncertain cost-effectiveness. MSAC acknowledged the focussed eligible patient population was better targeted to an unmet clinical need for this device and accepted the clinical effectiveness claim albeit supported by low quality data.
Details
Project Status: Completed
Year Published: 2015
URL for published report: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1365-public
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Hearing
  • Patient Satisfaction
  • Speech Perception
  • Treatment Outcome
  • Hearing Aids
  • Hearing Loss, Sensorineural
  • Ossicular Prosthesis
Contact
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name: msac.secretariat@health.gov.au
Contact Email: msac.secretariat@health.gov.au
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.